‘The Court Jester’
Court jesters reveal truths like no other.
How appropriate then, that someone who typically plays the ‘village idiot’ comes out with the truth.
Whether the ‘false narrative’ is finally crumbling or not, is not directly related to analyzing price action.
It does, however, provide the backdrop.
The ‘Big Reveal’
The last update in biotech had this to say (emphasis added):
“If this is the big reversal and biotech is the downside leader, unfortunately, that could mean a planned ‘reveal’ by the mainstream media.“
What wasn’t known, was just exactly how the truth would come out. Now, we know.
All of which, brings us to the topic at hand: Biotech SPBIO.
It turns out, SPBIO, is trading most consistently, on a three-day pattern.
Biotech SPBIO, 3-Day
In Wyckoff terms, the market itself defines what timeframes and what support/resistance levels are important.
Next up, we’re going to invert the chart to mimic the price action observed on the leveraged inverse fund LABD.
Biotech SPBIO, 3-Day, Inverted
And now, the characteristics of this sector the market itself, has revealed.
At this juncture, SPBIO, trades in a sequence of 3-Days after which, if there’s a directional move, continues on for nine consecutive bars.
After nine-bars, price action typically enters a correction for an undetermined amount of time.
After the correction’s compete the market has (in the past) continued on a directional move for another nine-bars.
Then & Now
We’re currently in a directional move that’s five ‘3-Day Bars’ in thus far.
If the market adheres to its prior behavior(s), we have at least four more ‘three-days’ to go (not advice, not a recommendation).
Note, the current reversal was identified to the day, with this update:
“However, today’s action is consistent with resolution of the five-months of congestion (not advice, not a recommendation).”
The fact the congestion period for SPBIO has taken so long to (apparently) resolve itself, has produced the potential for price action to go farther, last longer than anyone would normally expect.
That move if it happens, connects well with the introduction at the top of this post; a large part of the public has been informed in no uncertain terms, it was all a lie.
The needle, and the damage done.
Charts by StockCharts
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point®, trade mark: No. 6,505,279